DRUG NEWS: HAART decreases death rates by 80%

$3.95
Nursing2014
February 2004 
Volume 34  Number 2
Pages 24 - 24
 
  PDF Version Available!

ABSTRACT
Outline

  • First human trial of Ebola vaccine under way

  • Source

    Drug combinations known as highly active antiretroviral therapy (HAART) have reduced mortality rates from AIDS by more than 80%, according to researchers. Introduced in 1997, HAART is a combination of three or more drugs from at least two classes of antiretroviral drugs. It's designed to attack HIV in various stages of its life cycle.

    Because of HAART, 9 out of 10 people with AIDS can expect to live at least 10 years after infection. Although people older than 45 at diagnosis had a poorer prognosis in the pre-HAART era, older people on HAART have the same life expectancy as younger people.

    However, injecting drug users are four times more likely to die of AIDS than men infected through sexual contact, possibly because they're less likely to follow the complicated drug regimen and more likely to have certain other infections, such as hepatitis C.

    First ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!


Cost:$3.95
1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Password


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.


Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.






jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.


Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.


Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events